![R. Townsend](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
R. Townsend
Chief Executive Officer at
LEXEO THERAPEUTICS, INC.
Net worth: 2 M $ as of 2026-05-30
Profile
R.
Nolan Townsend is Chief Executive Officer & Director at Lexeo Therapeutics, Inc. since 2024, Director at Biotechnology Innovation Organization since 2023, and Director at Arbor Biotechnologies, Inc. since 2023.
Formerly, served as Chairman at Life Science Cares New York from 2022 to 2024 and Principal at Pfizer Inc. from 2008 to 2020.
Education includes an undergraduate degree from the University of Pennsylvania in 2002 and an MBA from Harvard Business School in 2007.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-17 | 336,764 ( 0.43% ) | 2 M $ | 2026-05-30 |
R. Townsend active positions
| Companies | Position | Start |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Chief Executive Officer | 2019-12-31 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Director/Board Member | 2023-09-30 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Director/Board Member | 2023-09-30 |
Former positions of R. Townsend
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 2019-12-31 |
Training of R. Townsend
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
- Stock Market
- Insiders
- R. Townsend
